ArticleBMC infectious diseases2025
Establishment and validation of a nomogram for predicting severe fever with thrombocytopenia syndrome complicated by invasive pulmonary aspergillosis.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The impact of different therapies on invasive pulmonary aspergillosis in patients with severe fever and thrombocytopenia syndrome: a systematic review and meta-analysis.Frontiers in public health · 2026Pooled it
- Development and validation of an interpretable machine learning model for the early diagnosis of invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: a retrospective cohort study.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesSevere fever with thrombocytopenia syndrome (SFTS) complicated by invasive pulmonary aspergillosis (IPA) is associated with high incidence and mortality. This study aimed to develop a clinically practical predictive model for assessing the risk of IPA in SFTS patients, thereby enabling early identification of high-risk patients and improving treatment strategies and prognosis.
methodsA retrospective analysis was conducted on patients diagnosed with SFTS at Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, from January 2016 to June 2024. These patients were classified into IPA and non-IPA groups and randomly divided into a training set and a validation set at a 7:3 ratio. Variables with statistical significance were incorporated into a multivariate logistic regression to construct a predictive model and develop a nomogram. The discrimination, calibration, and clinical applicability of the predictive model were evaluated using receiver operating characteristic (ROC) curve analysis, calibration curve assessment, and decision curve analysis (DCA), respectively. Internal validation was performed using the Bootstrap method.
resultsA total of 360 SFTS patients were enrolled, among whom 72 (20%) were diagnosed with IPA. Univariate analysis initially identified 16 variables (P < 0.05). Subsequent least absolute shrinkage and selection operator (LASSO) regression with 10-fold cross-validation reduced these to eight variables. Multivariate logistic regression further identified four independent risk factors: maximum viral load, total white blood cell (WBC) count, blood urea nitrogen (BUN), and activated partial thromboplastin time (APTT). A nomogram was constructed with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.76 (95% CI: 0.70–0.83) in the training set and 0.75 (95% CI: 0.63–0.87) in the validation set. The optimal cut-off value of the total nomogram score for each patient, determined using X-Tile software, enabled stratification of patients into three risk groups. The incidence of IPA was significantly higher in the high-risk group compared with the low-risk group (RR = 6.97, 95% CI: 3.60–13.48, P < 0.001).
conclusionsMaximum viral load, total WBC count, BUN, and APTT are independent risk factors for the early identification of IPA in SFTS patients. The predictive model demonstrated good predictive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.